株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の放射性医薬品市場規模調査:放射性同位体別、供給源別、用途別、エンドユーザー別、および地域別予測

Global Radiopharmaceuticals Market Size study, by Radioisotope, by Source, by Application, by End-User and Regional Forecasts 2019-2026

発行 Bizwit Research & Consulting LLP 商品コード 871558
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
世界の放射性医薬品市場規模調査:放射性同位体別、供給源別、用途別、エンドユーザー別、および地域別予測 Global Radiopharmaceuticals Market Size study, by Radioisotope, by Source, by Application, by End-User and Regional Forecasts 2019-2026
出版日: 2019年05月15日 ページ情報: 英文
概要

当レポートでは世界の放射性医薬品市場について調査しており、市場の成長要因・阻害要因、放射性同位体・供給源・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場のスナップショット
  • 主要傾向
  • 全体およびセグメント別市場予測
    • 放射性同位体別
    • 供給源別
    • 用途別
    • エンドユーザー別
    • 地域別
  • 調査方法
  • 調査の前提条件

第2章 放射性医薬品市場の定義と範囲

  • 研究の目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 研究のために考慮された年
  • 為替レート

第3章 放射性医薬品市場のダイナミクス

  • シーソー分析
    • 市場成長要因
    • 市場の課題
    • 市場機会

第4章 放射性医薬品市場分析

  • ポーターのファイブフォース分析
    • バイヤーの交渉力
    • サプライヤーの交渉力
    • 新規参入の脅威
    • 代用品の脅威
    • 業界内の競争
    • ポーターのファイブフォース分析への将来的アプローチ
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
  • 主な購入基準
  • 規制の枠組み
  • 投資/導入シナリオ
  • アナリストの提言と結論

第5章 放射性医薬品市場:放射性同位体別

  • 市場のスナップショット
  • 市場実績 - ポテンシャルモデル
  • 主要市場参入企業
  • 放射性医薬品市場、サブセグメント分析
    • テクネチウム99
    • ガリウム67
    • ヨウ素123
    • フッ素18
    • ルビジウム82
    • イットリウム90
    • ルテチウム177

第6章 放射性医薬品市場:供給源別

  • 市場のスナップショット
  • 市場実績 - ポテンシャルモデル
  • 主要市場参入企業
  • 放射性医薬品市場、サブセグメント分析
    • 原子炉
    • サイクロトロン

第7章 放射性医薬品市場:用途別

  • 市場のスナップショット
  • 市場実績 - ポテンシャルモデル
  • 主要市場参入企業
  • 放射性医薬品市場、サブセグメント分析
    • 循環器
    • 消化器科
    • 腫瘍学
    • 腎臓学
    • 神経学
    • 免疫学
    • その他

第8章 放射性医薬品市場:エンドユーザー別

  • 市場のスナップショット
  • 市場実績 - ポテンシャルモデル
  • 主要市場参入企業
  • 放射性医薬品市場、サブセグメント分析
    • 病院
    • 外来手術センター
    • 診断センター
    • その他

第9章 地域分析別放射性医薬品の市場

  • 放射性医薬品市場、地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • その他の欧州
  • アジア
    • 中国
    • インド
    • 日本
    • その他のアジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の世界の地域
    • 南米
    • 中東およびアフリカ

第10章 競合情勢

  • 企業の市場シェア(データの入手可能性別)
  • トップ市場戦略
  • 企業プロファイル
    • Advanced Accelerator Applications (AAA)
    • Bayer AG
    • Eckert & Ziegler
    • GE Healthcare
    • IBA Radiopharma Solutions
    • Lantheus Holdings Inc.
    • Mallinckrodt Plc
    • Nordion Inc.
    • Positron Corporation
    • Siemens Healthineers

第11章 調査方法

  • 調査方法
    • データマイニング
    • 分析
    • 市場予測
    • 検証
    • 出版
    • 調査の前提条件
図表

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF RADIOPHARMACEUTICALS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF RADIOPHARMACEUTICALS MARKET
  • TABLE 3. RADIOPHARMACEUTICALS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY RADIOISOTOPE 2016-2026 (USD BILLION)
  • TABLE 8. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SOURCE 2016-2026 (USD BILLION)
  • TABLE 9. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
  • TABLE 10. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
  • TABLE 11. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 31. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 34. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 40. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 43. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 46. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 47. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 48. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 53. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 57. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 58. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 59. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 61. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 62. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 63. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 64. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 65. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 66. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 67. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 68. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 69. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 70. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 71. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 72. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 73. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 74. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 75. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 76. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 77. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 78. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 79. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 80. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 81. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 82. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 83. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 84. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 85. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 86. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 87. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 88. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 89. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 90. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 91. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 92. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 93. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 94. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 95. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 96. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 97. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 98. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 99. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 100. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 101. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 102. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 103. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 104. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 105. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 106. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 107. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 108. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 109. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 110. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 111. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. RADIOPHARMACEUTICALS MARKET, RESEARCH METHODOLOGY
  • FIG 2. RADIOPHARMACEUTICALS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. RADIOPHARMACEUTICALS MARKET, KEY TRENDS 2017
  • FIG 5. RADIOPHARMACEUTICALS MARKET, GROWTH PROSPECTS 2018-2026
  • FIG 6. RADIOPHARMACEUTICALS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. RADIOPHARMACEUTICALS MARKET, PEST ANALYSIS
  • FIG 8. RADIOPHARMACEUTICALS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 19. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 20. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 21. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 22. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 23. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 24. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 25. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 26. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 27. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 28. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 29. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 30. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 31. RADIOPHARMACEUTICALS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 32. NORTH AMERICA RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLON)
  • FIG 33. EUROPE RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLON)
  • FIG 34. ASIA PACIFIC RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLON)
  • FIG 35. LATIN AMERICA RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLON)
  • FIG 36. RADIOPHARMACEUTICALS MARKET, COMPANY MARKET SHARE ANALYSIS (2017)
目次

Global Radiopharmaceuticals Market valued approximately USD 5.72 billion in 2018 is anticipated to grow with a healthy growth rate of more than 5.60% over the forecast period 2019-2026. The Radiopharmaceuticals Market is continuously growing in the global scenario at significant pace. Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities. Increasing incidence of cardiovascular diseases, growing preference for PET and SPET scans, rise in consciousness about positive effects and enhancements in radiotracers are the substantial driving factors of the market during the forecast period. Moreover, increase in use of radiopharmaceuticals in neurological applications are the factors that likely to create numerous opportunity in the near future. However, scarcity of radioisotopes, strict regulatory standards and high cost of the procedure are the factors that limiting the growth of the market during the forecast period.

The regional analysis of Global Radiopharmaceuticals Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share due to presence of excellent research facilities and rising healthcare expenditure in the region. Europe is estimated to grow at stable growth rate in the global Radiopharmaceuticals market over the upcoming years. Further, Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to rising demand for PET and SPECT devices and rising patient awareness levels pertaining to cardiovascular diseases and oncology in the region.

The major market player included in this report are:

  • Advanced Accelerator Applications (AAA)
  • Bayer AG
  • Eckert & Ziegler
  • GE Healthcare
  • IBA Radiopharma Solutions
  • Lantheus Holdings Inc.
  • Mallinckrodt Plc
  • Nordion Inc.
  • Positron Corporation
  • Siemens Healthineers

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Radioisotope:

  • Technetium-99
  • Gallium-67
  • Iodine-123
  • 18F
  • Rubidium-82
  • Yttrium-90
  • Lutetium-177
  • By Source:
  • Nuclear Reactors
  • Cyclotrons

By Application:

  • Cardiology
  • Gastroenterology
  • Oncology
  • Nephrology
  • Neurology
  • Immunology
  • Others

By End-User:

  • Hospitals
  • Ambulatory Surgical Centers

    Diagnostic Centers

    Others

By Regions:

    North America

    U.S.

    Canada

    Europe

    UK

    Germany

    Asia Pacific

    China

    India

    Japan

    Latin America

    Brazil

    Mexico

    Rest of the World

Furthermore, years considered for the study are as follows:

    Historical year - 2016, 2017

    Base year - 2018

    Forecast period - 2019 to 2026

Target Audience of the Global Radiopharmaceuticals Market in Market Study:

    Key Consulting Companies & Advisors

    Large, medium-sized, and small enterprises

    Venture capitalists

    Value-Added Resellers (VARs)

    Third-party knowledge providers

    Investment bankers

    Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
    • 1.3.1. Radiopharmaceuticals Market, by Radioisotope, 2016-2026 (USD Billion)
    • 1.3.2. Radiopharmaceuticals Market, by Source, 2016-2026 (USD Billion)
    • 1.3.3. Radiopharmaceuticals Market, by Application, 2016-2026 (USD Billion)
    • 1.3.4. Radiopharmaceuticals Market, by End-User, 2016-2026 (USD Billion)
    • 1.3.5. Radiopharmaceuticals Market, by Region, 2016-2026 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Radiopharmaceuticals Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Radiopharmaceuticals Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Radiopharmaceuticals Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria
  • 4.4. Regulatory Framework
  • 4.5. Investment Vs Adoption Scenario
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Radiopharmaceuticals Market, by Radioisotope

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. Radiopharmaceuticals Market, Sub Segment Analysis
    • 5.4.1. Technetium-99
      • 5.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.2. Gallium-67
      • 5.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.3. Iodine-123
      • 5.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.4. 18F
      • 5.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.5. Rubidium-82
      • 5.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.6. Yttrium-90
      • 5.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.7. Lutetium-177
      • 5.4.7.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.7.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6. Radiopharmaceuticals Market, by Source

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. Radiopharmaceuticals Market, Sub Segment Analysis
    • 6.4.1. Nuclear Reactors
      • 6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.2. Cyclotrons
      • 6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7. Radiopharmaceuticals Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Market Performance - Potential Model
  • 7.3. Key Market Players
  • 7.4. Radiopharmaceuticals Market, Sub Segment Analysis
    • 7.4.1. Cardiology
      • 7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.2. Gastroenterology
      • 7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.3. Oncology
      • 7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.4. Nephrology
      • 7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.5. Neurology
      • 7.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.6. Immunology
      • 7.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.7. Others
      • 7.4.7.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.7.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Radiopharmaceuticals Market, by End-User

  • 8.1. Market Snapshot
  • 8.2. Market Performance - Potential Model
  • 8.3. Key Market Players
  • 8.4. Radiopharmaceuticals Market, Sub Segment Analysis
    • 8.4.1. Hospitals
      • 8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.2. Ambulatory Surgical Centers
      • 8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.3. Diagnostic Centers
      • 8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.4. Others
      • 8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 9. Radiopharmaceuticals Market, by Regional Analysis

  • 9.1. Radiopharmaceuticals Market, Regional Market Snapshot (2016-2026)
  • 9.2. North America Radiopharmaceuticals Market Snapshot
    • 9.2.1. U.S.
      • 9.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.1.3. Sources breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.2.2. Canada
      • 9.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 9.3. Europe Radiopharmaceuticals Market Snapshot
    • 9.3.1. U.K.
      • 9.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.3.2. Germany
      • 9.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.3.3. Rest of Europe
      • 9.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.3.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.3.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.3.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.3.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 9.4. Asia Radiopharmaceuticals Market Snapshot
    • 9.4.1. China
      • 9.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.1.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.4.2. India
      • 9.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.4.3. Japan
      • 9.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.3.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.3.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.3.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.3.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.4.4. Rest of Asia Pacific
      • 9.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.4.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.4.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.4.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.4.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 9.5. Latin America Radiopharmaceuticals Market Snapshot
    • 9.5.1. Brazil
      • 9.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.1.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.5.2. Mexico
      • 9.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 9.6. Rest of The World
    • 9.6.1. South America
      • 9.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.1.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.6.2. Middle East and Africa
      • 9.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 10. Competitive Intelligence

  • 10.1. Company Market Share (Subject to Data Availability)
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Advanced Accelerator Applications (AAA)
      • 10.3.1.1. Overview
      • 10.3.1.2. Financial (Subject to Data Availability)
      • 10.3.1.3. Summary
      • 10.3.1.4. Recent Developments
    • 10.3.2. Bayer AG
    • 10.3.3. Eckert & Ziegler
    • 10.3.4. GE Healthcare
    • 10.3.5. IBA Radiopharma Solutions
    • 10.3.6. Lantheus Holdings Inc.
    • 10.3.7. Mallinckrodt Plc
    • 10.3.8. Nordion Inc.
    • 10.3.9. Positron Corporation
    • 10.3.10. Siemens Healthineers

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
    • 11.1.6. Research Assumption
Back to Top